Longfellow Investment Management Co. LLC Has $882,000 Position in Marsh & McLennan Companies, Inc. $MRSH

Longfellow Investment Management Co. LLC grew its holdings in Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 25,652.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,378 shares of the financial services provider’s stock after purchasing an additional 4,361 shares during the period. Longfellow Investment Management Co. LLC’s holdings in Marsh & McLennan Companies were worth $882,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Pinnacle Bancorp Inc. bought a new position in shares of Marsh & McLennan Companies in the 3rd quarter valued at about $25,000. Headlands Technologies LLC acquired a new position in Marsh & McLennan Companies during the second quarter valued at approximately $29,000. Delos Wealth Advisors LLC acquired a new position in shares of Marsh & McLennan Companies during the 2nd quarter worth approximately $32,000. TruNorth Capital Management LLC acquired a new stake in shares of Marsh & McLennan Companies in the 3rd quarter valued at approximately $32,000. Finally, Hanson & Doremus Investment Management grew its stake in shares of Marsh & McLennan Companies by 31.3% in the third quarter. Hanson & Doremus Investment Management now owns 214 shares of the financial services provider’s stock valued at $43,000 after buying an additional 51 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. JPMorgan Chase & Co. cut their price target on shares of Marsh & McLennan Companies from $242.00 to $226.00 and set an “overweight” rating for the company in a research note on Wednesday, January 7th. Keefe, Bruyette & Woods lifted their price target on Marsh & McLennan Companies from $205.00 to $206.00 and gave the stock a “market perform” rating in a report on Monday, February 2nd. Morgan Stanley upped their price objective on Marsh & McLennan Companies from $190.00 to $195.00 and gave the company an “equal weight” rating in a research note on Friday, January 30th. Barclays raised their price objective on Marsh & McLennan Companies from $206.00 to $210.00 and gave the company an “overweight” rating in a research report on Thursday, January 8th. Finally, Evercore decreased their target price on Marsh & McLennan Companies from $237.00 to $236.00 and set an “outperform” rating on the stock in a report on Wednesday, January 7th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $216.18.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the business’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer owned 116,811 shares of the company’s stock, valued at $21,411,456.30. The trade was a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.35% of the stock is owned by company insiders.

Marsh & McLennan Companies Stock Performance

Shares of NYSE:MRSH opened at $184.91 on Friday. Marsh & McLennan Companies, Inc. has a 12-month low of $170.37 and a 12-month high of $248.00. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.10 and a quick ratio of 1.10. The company has a market cap of $89.52 billion, a PE ratio of 21.93, a PEG ratio of 2.51 and a beta of 0.74.

Marsh & McLennan Companies (NYSE:MRSH) last released its quarterly earnings results on Thursday, January 29th. The financial services provider reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.97 by $0.15. Marsh & McLennan Companies had a return on equity of 31.60% and a net margin of 15.42%.The business had revenue of $6.60 billion during the quarter, compared to analysts’ expectations of $6.52 billion. During the same period last year, the firm posted $1.87 EPS. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, analysts expect that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.

Marsh & McLennan Companies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Thursday, April 9th. Marsh & McLennan Companies’s dividend payout ratio (DPR) is currently 42.70%.

More Marsh & McLennan Companies News

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Recent quarterly results and a new dividend reinforce fundamentals: MMCo reported an earnings beat and revenue growth, and the company declared a $0.90 quarterly dividend (ex-dividend April 9, payable May 15), which supports income-oriented demand. John Doyle Sells 16,655 Shares of Marsh & McLennan Companies (NYSE:MRSH) Stock
• Positive Sentiment: Analyst coverage is mixed-to-favorable: some firms maintained or raised targets (including a Raymond James upgrade) and consensus price targets remain above the current level, which can underpin buying interest. Analysts Set Marsh (NYSE:MRSH) Target Price at $207.38
• Neutral Sentiment: Market write-ups and peer comparisons continue to circulate (analyst notes / comparison pieces) but don’t introduce new company-specific catalysts; they provide context for relative valuation and may influence longer-term flows rather than intraday moves. Comparing Marsh & McLennan Companies (NYSE:MRSH) & Health In Tech (NASDAQ:HIT)
• Negative Sentiment: CEO John Q. Doyle sold 16,655 shares (~$3.05M at ~$183.30), reducing his stake by ~12.5%. Insider selling can weigh on sentiment because it may be interpreted as reduced insider conviction or a signal of liquidity needs. John Doyle Sells 16,655 Shares of Marsh & McLennan Companies (NYSE:MRSH) Stock
• Negative Sentiment: Legal risk: a Bloomberg Law ruling requires Marsh & McLennan to face a fiduciary-breach case tied to health-plan management — this introduces litigation risk and potential remediation costs that can cap valuation multiple until resolved. Marsh & McLennan Must Face Health Plan Fiduciary Breach Case

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.